Pharmacokinetic interactions between simvastatin and setipiprant, a CRTH2 antagonist

被引：0
|
作者：
Martine Gehin
Patricia N. Sidharta
Carmela Gnerre
Alexander Treiber
Atef Halabi
Jasper Dingemanse
机构：
[1] Actelion Pharmaceuticals Ltd,Department of Clinical Pharmacology
[2] Actelion Pharmaceuticals Ltd,Department of DMPK
[3] CRS,undefined
来源：
European Journal of Clinical Pharmacology | 2015年 / 71卷
关键词：
Setipiprant; CRTH2; CYP3A4; Drug-drug interaction study; Simvastatin; Simvastatin acid;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：15 / 23
页数：8
相关论文
共 50 条
  • [1] Pharmacokinetic interactions between simvastatin and setipiprant, a CRTH2 antagonist
    Gehin, Martine
    Sidharta, Patricia N.
    Gnerre, Carmela
    Treiber, Alexander
    Halabi, Atef
    Dingemanse, Jasper
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2015, 71 (01) : 15 - 23
  • [2] Disposition and metabolism of Setipiprant, a selective oral CRTH2 antagonist, in humans
    Hoch M.
    Wank J.
    Kluge I.
    Wagner-Redeker W.
    Dingemanse J.
    Drugs in R&D, 2013, 13 (4) : 253 - 269
  • [3] EFFECT OF MULTIPLE-DOSE SETIPIPRANT, A SELECTIVE ORAL CRTH2 ANTAGONIST, ON THE PHARMACOKINETICS OF SINGLE-DOSE SIMVASTATIN IN HEALTHY MALE SUBJECTS
    Gehin, M.
    Mackie, A.
    Sidharta, P. N.
    Kadlecova, P.
    Petersen-Sylla, M.
    Halabi, A.
    Dingemanse, J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2013, 93 : S42 - S42
  • [4] Setipiprant, a selective CRTH2 antagonist, reduces allergen-induced airway responses in allergic asthmatics
    Diamant, Z.
    Sidharta, P. N.
    Singh, D.
    O'Connor, B. J.
    Zuiker, R.
    Leaker, B. R.
    Silkey, M.
    Dingemanse, J.
    CLINICAL AND EXPERIMENTAL ALLERGY, 2014, 44 (08): : 1044 - 1052
  • [5] Single- and multiple-dose tolerability and pharmacokinetics of the CRTH2 antagonist setipiprant in healthy male subjects
    Sidharta, Patricia N.
    Diamant, Zuzana
    Dingemanse, Jasper
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2014, 28 (06) : 690 - 699
  • [6] Minor structural modifications convert the dual TP/CRTH2 antagonist ramatroban into a highly selective and potent CRTH2 antagonist
    Ulven, T
    Kostenis, E
    JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (04) : 897 - 900
  • [7] Setipiprant, a Selective Oral Antagonist of Human CRTH2: Relative Bioavailability of a Capsule and a Tablet Formulation in Healthy Female and Male Subjects
    Baldoni, Daniela
    Mackie, Alison
    Gutierrez, Marcelo
    Theodor, Rudolf
    Dingemanse, Jasper
    CLINICAL THERAPEUTICS, 2013, 35 (11) : 1842 - 1848
  • [8] CRTH2
    Nagata, K
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2003, 17 (04): : 334 - 337
  • [9] Discovery of AMG 853, a CRTH2 and DP Dual Antagonist
    Liu, Jiwen
    Li, An-Rong
    Wang, Yingcai
    Johnson, Mike G.
    Su, Yongli
    Shen, Wang
    Wang, Xuemei
    Lively, Sarah
    Brown, Matthew
    Lai, SuJen
    Gonzalez, Felix
    De Turiso, Lopez
    Xu, Qingge
    Van Lengerich, Bettina
    Schmitt, Mike
    Fu, Zice
    Sun, Ying
    Lawlis, Shanna
    Seitz, Lisa
    Danao, Jay
    Wait, Jill
    Ye, Qiuping
    Tang, Hua Lucy
    Grillo, Mark
    Collins, Tassie L.
    Sullivan, Timothy F.
    Medina, Julio C.
    ACS MEDICINAL CHEMISTRY LETTERS, 2011, 2 (05): : 326 - 330
  • [10] Development of a Practical and Scalable Synthesis of a Potent CRTH2 Antagonist
    Yoshida, Shinya
    Yoshino, Toshitaka
    Miyafuji, Akio
    Yasuda, Hironobu
    Kimura, Takenori
    Takahashi, Takumi
    Mukuta, Takashi
    ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2012, 16 (09) : 1544 - 1551
12345